KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Construction in Progress: 2016-2025

Historic Construction in Progress for BeOne Medicines (ONC) over the last 7 years, with Sep 2025 value amounting to $129.1 million.

  • BeOne Medicines' Construction in Progress fell 79.36% to $129.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $129.1 million, marking a year-over-year decrease of 79.36%. This contributed to the annual value of $654.0 million for FY2024, which is 11.69% down from last year.
  • Per BeOne Medicines' latest filing, its Construction in Progress stood at $129.1 million for Q3 2025, which was down 63.49% from $353.7 million recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Construction in Progress ranged from a high of $863.4 million in Q2 2024 and a low of $70.8 million during Q1 2021.
  • Over the past 3 years, BeOne Medicines' median Construction in Progress value was $625.6 million (recorded in 2024), while the average stood at $566.5 million.
  • Per our database at Business Quant, BeOne Medicines' Construction in Progress skyrocketed by 184.02% in 2023 and then slumped by 79.36% in 2025.
  • Over the past 5 years, BeOne Medicines' Construction in Progress (Quarterly) stood at $186.8 million in 2021, then skyrocketed by 57.15% to $293.6 million in 2022, then skyrocketed by 152.23% to $740.6 million in 2023, then declined by 11.69% to $654.0 million in 2024, then crashed by 79.36% to $129.1 million in 2025.
  • Its last three reported values are $129.1 million in Q3 2025, $353.7 million for Q2 2025, and $590.0 million during Q1 2025.